These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22551540)

  • 1. Episcleral brachytherapy for uveal melanoma: analysis of 136 cases.
    García-Álvarez C; Saornil MA; López-Lara F; Almaraz A; Muñoz MF; Frutos-Baraja J; Muiños Y
    Clin Transl Oncol; 2012 May; 14(5):350-5. PubMed ID: 22551540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit.
    Sánchez-Tabernero S; García-Alvarez C; Muñoz-Moreno MF; Diezhandino P; Alonso-Martínez P; de Frutos-Baraja JM; López-Lara F; Saornil MA
    Am J Ophthalmol; 2017 Aug; 180():39-45. PubMed ID: 28572063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
    Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
    Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of visual function in posterior uveal melanoma patients treated with I125 episcleral brachytherapy in a Spanish referral Ocular Oncology Unit.
    Vicente N; Saornil MA; Almaraz A; Muñoz-Moreno MF
    Arq Bras Oftalmol; 2021; 84(4):330-338. PubMed ID: 33567036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-I25 episcleral plaque therapy in uveal melanoma.
    Sia S; Harper C; McAllister I; Perry A
    Clin Exp Ophthalmol; 2000 Dec; 28(6):409-13. PubMed ID: 11202462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension.
    Augsburger JJ; Schneider S; Narayana A; Breneman JC; Aron BS; Barrett WL; Trichopoulos N
    Can J Ophthalmol; 2004 Jun; 39(4):380-7. PubMed ID: 15327103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
    Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
    JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
    Perez BA; Mettu P; Vajzovic L; Rivera D; Alkaissi A; Steffey BA; Cai J; Stinnett S; Dutton JJ; Buckley EG; Halperin E; Marks LB; Mruthyunjaya P; Kirsch DG
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):127-36. PubMed ID: 24613808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
    King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
    Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small choroidal melanoma: outcomes following apical height dose brachytherapy.
    Yupari RJ; Bena J; Wilkinson A; Suh J; Singh A
    Br J Ophthalmol; 2021 Aug; 105(8):1161-1165. PubMed ID: 32878827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspected vitreous seeding of uveal melanoma: relevance of diagnostic vitrectomy.
    Metz CH; Bornfeld N; Metz KA; Gök M
    Br J Ophthalmol; 2016 May; 100(5):660-4. PubMed ID: 26359338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.
    van Ginderdeuren R; van Limbergen E; Spileers W
    Br J Ophthalmol; 2005 Oct; 89(10):1306-10. PubMed ID: 16170122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iodine Plaque Brachytherapy a Customized Conservative Approach to the Management of Medium/Large-sized Uveal Melanoma.
    Laliscia C; Perrone F; Cresti F; Guido F; Fuentes T; Trippa C; Paiar F; Pellegrini G; Ebert FG
    In Vivo; 2024; 38(4):1814-1822. PubMed ID: 38936895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
    Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
    Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium-106 plaque brachytherapy for uveal melanoma.
    Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
    Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience.
    Perri P; Fiorica F; D'Angelo S; Lamberti G; Parmeggiani F; Martini A; Carpenteri F; Colosimo C; Micucci M; Perazzini L; De Gugliemo E; Berretta M; Sebastiani A; Cartei F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1919-24. PubMed ID: 23242717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.